BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 29120654)

  • 1. [Diagnosis and management of metastatic pheochromocytoma and paraganglioma].
    Jochmanová I; Lazúrová I
    Vnitr Lek; 2017; 63(9):580-588. PubMed ID: 29120654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
    Moraitis AG; Martucci VL; Pacak K
    Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
    Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
    Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pediatric pheochromocytoma and paraganglioma: an update].
    Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
    Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma.
    Castinetti F; Kroiss A; Kumar R; Pacak K; Taieb D
    Endocr Relat Cancer; 2015 Aug; 22(4):T135-45. PubMed ID: 26045470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phaeochromocytoma and paraganglioma].
    Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
    Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pheochromocytoma and abdominal paraganglioma.
    Renard J; Clerici T; Licker M; Triponez F
    J Visc Surg; 2011 Dec; 148(6):e409-16. PubMed ID: 21862435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study.
    Schovanek J; Martucci V; Wesley R; Fojo T; Del Rivero J; Huynh T; Adams K; Kebebew E; Frysak Z; Stratakis CA; Pacak K
    BMC Cancer; 2014 Jul; 14():523. PubMed ID: 25048685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience.
    De Filpo G; Cantini G; Rastrelli G; Vannini G; Ercolino T; Luconi M; Mannelli M; Maggi M; Canu L
    J Endocrinol Invest; 2022 Jan; 45(1):149-157. PubMed ID: 34227051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytomas and Paragangliomas.
    Tevosian SG; Ghayee HK
    Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.
    Vicha A; Musil Z; Pacak K
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):186-91. PubMed ID: 23481210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.
    Eid M; Foukal J; Sochorová D; Tuček Š; Starý K; Kala Z; Mayer J; Němeček R; Trna J; Kunovský L
    Cancer Med; 2023 Jul; 12(13):13942-13957. PubMed ID: 37145019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pheochromocytomas and paragangliomas in humans and dogs.
    Galac S; Korpershoek E
    Vet Comp Oncol; 2017 Dec; 15(4):1158-1170. PubMed ID: 28120550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
    Fishbein L; Del Rivero J; Else T; Howe JR; Asa SL; Cohen DL; Dahia PLM; Fraker DL; Goodman KA; Hope TA; Kunz PL; Perez K; Perrier ND; Pryma DA; Ryder M; Sasson AR; Soulen MC; Jimenez C
    Pancreas; 2021 Apr; 50(4):469-493. PubMed ID: 33939658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic paraganglioma.
    Lee JA; Duh QY
    World J Surg; 2008 May; 32(5):683-7. PubMed ID: 18224469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma and paraganglioma.
    Meyer-Rochow GY; Sidhu SB
    Cancer Treat Res; 2010; 153():135-62. PubMed ID: 19957224
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pheochromocytoma and paraganglioma in childhood: a report of 2 cases report].
    Mosquera Gorostidi A; Justo Ranera A; Zakirian Denis SE; González Temprano N; Sagaseta de Ilúrdoz Uranga M; Molina Garicano J
    An Pediatr (Barc); 2015 Jan; 82(1):e175-80. PubMed ID: 25082130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation and treatment of phaeochromocytoma.
    Davison AS; Jones DM; Ruthven S; Helliwell T; Shore SL
    Ann Clin Biochem; 2018 Jan; 55(1):34-48. PubMed ID: 29027806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.